Codeveloped by the American Heart Association and the American Red Cross, these guidelines represent the first comprehensive ...
BACKGROUND: Many studies have explored whether individual plasma protein biomarkers improve cardiovascular disease risk ...
BACKGROUND: The ability to predict recovery of left ventricular ejection fraction (LVEF) in response to guideline-directed therapy among patients with nonischemic cardiomyopathy is desired. We sought ...
BACKGROUND: Patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction commonly experience ...
BACKGROUND: Blood pressure (BP)–lowering effects of structured exercise are well-established. Effects of 24-hour movement ...
Kawasaki disease (KD), an acute self-limited febrile illness that primarily affects children <5 years old, is the leading cause of acquired heart disease in developed countries, with the potential of ...
BACKGROUND: Allogeneic stem cell transplantation (allo-SCT) is an efficacious treatment for hematologic malignancies but can ...
Introduction: Seismocardiography (SCG) - measurements of cardiovascular-induced vibrations on the chest - has shown potential for providing clinical information for cardiac conditions. SCG is ...
Introduction: Individuals with type 1 diabetes (T1D) complicated by impaired awareness of hypoglycemia (IAH) are at significantly increased risk for severe hypoglycemia: a marker of high risk of CVD.
The “2024 Guideline for the Primary Prevention of Stroke” replaces the 2014 “Guidelines for the Primary Prevention of Stroke.” This updated guideline is intended to be a resource for clinicians to use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback